EP2198007A4
Pharmaceutical compositions containing clostridium difficile toxoids a and b
23 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO2006020208A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| US2006099227A1 | Cites | United States of America | Search report |
| US2007134199A1 | Cites | United States of America | Search report |
| US6214341B1 | Cites | United States of America | Search report |
| WO9611699A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| GOODNOUGH M C ET AL: "STABILIZATION OF BOTULINUM TOXIN TYPE A DURING LYOPHILIZATION", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 58, no. 10, 1 January 1992 (1992-01-01), pages 3426 - 3428, XP001024270, ISSN: 0099-2240 | Non-patent | – | Search report |
| See also references of WO 2009035707A1 | Non-patent | – | Search report |
54 members in 21 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 972496P | United States of America | – | |
| 97249607 | United States of America | P | |
| 97249607 | United States of America | P | |
| 2008010767 | United States of America | W | |
| 2008010767 | United States of America | W | |
| 972496P | – | – | – |
| US20070972496P | – | – | – |
| US2008010767 | – | – | – |
| WO2008US10767 | – | – | – |
Members54
| Document | Office | Kind | |
|---|---|---|---|
| AU2008299885A1 | Australia | A1 | |
| CA2699435A1 | Canada | A1 | |
| WO2009035707A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2009035707A9 | World Intellectual Property Organization (WIPO) | A9 | |
| EP2198007A1 | European Patent Office (EPO) | A1 | |
| KR20100075912A | Republic of Korea | A | |
| KR20100075912A | Republic of Korea | A | |
| MX2010002815A | Mexico | A | |
| CN101855336A | China | A | |
| JP2010539172A | Japan | A | |
| US2011045025A1 | United States of America | A1 | |
| RU2010114730A | Russian Federation | A | |
| RU2010114730A | Russian Federation | A | |
| EP2198007A4This record | European Patent Office (EPO) | A4 | |
| IL204366A | Israel | A | |
| JP2014055174A | Japan | A | |
| JP5503543B2 | Japan | B2 | |
| BRPI0816790A2 | Brazil | A2 | |
| AU2008299885B2 | Australia | B2 | |
| AU2015201233A1 | Australia | A1 | |
| RU2550271C2 | Russian Federation | C2 | |
| AU2008299885C1 | Australia | C1 | |
| KR20160005378A | Republic of Korea | A | |
| KR20160005378A | Republic of Korea | A | |
| US9320790B2 | United States of America | B2 | |
| CN106039299A | China | A | |
| US2016317640A1 | United States of America | A1 | |
| KR101679812B1 | Republic of Korea | B1 | |
| KR101679812B1 | Republic of Korea | B1 | |
| EP3124044A1 | European Patent Office (EPO) | A1 | |
| AU2015201233B2 | Australia | B2 | |
| JP2017052773A | Japan | A | |
| BRPI0816790A8 | Brazil | A8 | |
| US9687541B2 | United States of America | B2 | |
| EP2198007B1 | European Patent Office (EPO) | B1 | |
| US2018000920A1 | United States of America | A1 | |
| JP6258674B2 | Japan | B2 | |
| DK2198007T3 | Denmark | T3 | |
| PT2198007T | Portugal | T | |
| HRP20180054T1 | Croatia | T1 | |
| ES2657485T3 | Spain | T3 | |
| NO2198007T3 | Norway | T3 | |
| PL2198007T3 | Poland | T3 | |
| SI2198007T1 | Slovenia | T1 | |
| HUE037932T2 | Hungary | T2 | |
| CY1119979T1 | Cyprus | T1 | |
| CN101855336B | China | B | |
| US10639362B2 | United States of America | B2 | |
| EP3124044B1 | European Patent Office (EPO) | B1 | |
| EP3124044C0 | European Patent Office (EPO) | C0 | |
| EP3124044B8 | European Patent Office (EPO) | B8 | |
| ES3001561T3 | Spain | T3 | |
| EP4537849A2 | European Patent Office (EPO) | A2 | |
| EP4537849A3 | European Patent Office (EPO) | A3 |
96 legal events, as 19 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapse because of not paying annual feesLapsedMM01 | MM01 | AT | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Publication of translation of european patent specificationUEP | UEP | AT | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapse of patentLapsedKO00 | KO00 | SI | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | BE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | NL | |
| Ep patent lapsedLapsedEBP | EBP | DK | |
| Ep patent has lapsedLapsedEUG | EUG | SE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed, nullified, void or expired european patent that had effect in norwayExpiredMMEP | MMEP | NO | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapse due to non-payment of renewal feeLapsedPBON | PBON | HR | |
| No opposition filedOpposition26N | 26N | EP | |
| Filing of the translation of the text of european patentsAG4A | AG4A | HU | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Ep patent validated in greeceEP | EP | GR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Entry of ep patent into national phase of norway [publ. of translation]T2 | T2 | NO | |
| Invalidated european patentMG4D | MG4D | LT | |
| Definitive protectionFG2A | FG2A | ES | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| Ep patent validated in croatiaT1PR | T1PR | HR | |
| Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A | SC4A | PT | |
| Translation for ep filed (entry of ep into country)FP | FP | NL | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Ep patent valid in romaniaEPE | EPE | RO | |
| Request for ep validation receivedTUEP | TUEP | HR | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Intention to grant announced (deleted)INTC | INTC | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA | STAA | EP | |
| Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deletedORIGINAL CODE: EPIDOSDIGR1GRAJ | GRAJ | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: EXAMINATION IS IN PROGRESSSTAA | STAA | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA | STAA | EP | |
| Amendment of ipc main classPREVIOUS MAIN CLASS: C12N0001200000R079 | R079 | DE | |
| First examination report despatched17Q | 17Q | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2198007
- Publication, DOCDB
- 2198007
- Publication, EPODOC
- EP2198007
- Application
- 8830210
- Application, DOCDB
- 08830210
- Application, EPODOC
- EP20080830210
Titles3
- German
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT CLOSTRIDIUM DIFFICILE TOXOIDEN A UND B
- English
- PHARMACEUTICAL COMPOSITIONS CONTAINING CLOSTRIDIUM DIFFICILE TOXOIDS A AND B
- French
- COMPOSITIONS PHARMACEUTIQUES CONTENANT LES ANATOXINES A ET B DE CLOSTRIDIUM DIFFICILE
Classification
- CPC, 15
- A61K39/08
- A61K9/0019
- A61K9/19
- A61K47/12
- A61K47/183
- A61K47/26
- A61K2039/55505
- A61K39/00
- A61K47/08
- A61P1/00
- A61P1/04
- A61P1/12
- A61P31/00
- A61P31/04
- A61P37/04
- IPC, 3
- C12N1 20
- A61K39 08
- A61K9 19
Designated states1
- Contracting states, 1
- Türkiye
